Financial Summary (All financials)
| In millions, except per share items | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 |
| Revenues | 722.2 | 643.2 | 643.2 | 421.4 |
| Revenue growth | 12.3% | 52.6% | | |
| Cost of goods sold | 642.2 | 488.2 | 488.2 | 292.1 |
| Gross profit | 80.0 | 155.0 | 155.0 | 129.2 |
| Gross margin | 11.1% | 24.1% | 24.1% | 30.7% |
| Selling, general and administrative | 412.8 | 353.9 | 353.9 | 167.8 |
| Research and development | 22.3 | 16.8 | 16.8 | 6.8 |
| EBIT | -396.0 | -213.7 | -213.7 | -47.1 |
| EBIT margin | -54.8% | -33.2% | -33.2% | -11.2% |
| Pre-tax income | -397.4 | -215.0 | -215.0 | -58.0 |
| Income taxes | -4.8 | 2.7 | -2.7 | -2.4 |
| Tax rate | 1.2% | | 1.2% | 4.2% |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | 0.0% | 0.0% | 0.0% | 0.0% |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares outstanding (diluted) | 592,031.9 | 549,080.3 | 549,080.3 | 454,266.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|